A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises-Reference-Cited by-同舟云学术

A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises

Published:2014 Issue:4 Volume:11 Page:371
ISSN:1738-3684
Container-title:Psychiatry Investigation
language:en
Short-container-title:Psychiatry Investig

Author:

Pae Chi-Un¹²,Seo Ho-Jun¹,Lee Boung Chul³,Seok Jeong-Ho⁴,Jeon Hong Jin⁵,Paik Jong-Woo⁶,Kwak Kyung-Phil⁷,Ham Byung-Joo⁸,Han Changsu⁸,Lee Soo-Jung¹

Affiliation:

1. Department of Psychiatry, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.

2. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Duram, NC, USA.

3. Department of Neuropsychiatry, College of Medicine, Hallym University, Seoul, Republic of Korea.

4. Department of Psychiatry, Yonsei University College of Medicine, Seoul, Republic of Korea.

5. Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

6. Department of Psychiatry, Kyunghee University College of Medicine, Seoul, Republic of Korea.

7. Department of Neuropsychiatry, School of Medicine, Dongguk University, Gyeongju, Republic of Korea.

8. Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea.

Publisher

Korean Neuropsychiatric Association

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference41 articles.

1. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability

2. The Epidemiology of Major Depressive Disorder

3. Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROTOCOL: Treatment for depressive disorder among adults: An evidence and gap map of systematic reviews;Campbell Systematic Reviews;2023-03

2. Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder;Clinical Psychopharmacology and Neuroscience;2021-05-31

3. Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report;Pharmacopsychiatry;2021-03-02

4. How effective is aripiprazole in treatment-resistant major depression?;Evidence-Based Practice;2019-07

5. “Salami Slicing” in Pooled Analyses of Second-Generation Antipsychotics for the Treatment of Depression;Psychotherapy and Psychosomatics;2017